Stefano Agnesi

Dr. Stefano Agnesi

General Surgery, Azienda Ospedaliera Bolognini Seriate, Seriate, Italy
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
CCClara Benedetta Conti
Clara Benedetta Conti
Stefano AgnesiStefano Agnesi
Stefano Agnesi
MSMiki Scaravaglio
Miki Scaravaglio
PMPietro Masseria
Pietro Masseria
MDMarco Emilio Dinelli
Marco Emilio Dinelli
FUFabio Uggeri
Fabio Uggeri
Gastric cancer (GC) is a relevant public health issue as its incidence and mortality rates are growing worldwide. There are recognized carcinogen agents, such as obesity, tobacco, meat, alcohol consumption and some dietary protective factors. Strategies of early diagnosis through population-based surveillance programs have been demonstrated to be effective in lowering the morbidity and mortality related to GC in some countries. Indeed, the detection of early lesions is very important in order to offer minimally invasive treatments. Endoscopic resection is the gold standard for lesions with a low risk of lymph node metastasis, whereas surgical mini-invasive approaches can be considered in early lesions when endoscopy is not curative. This review outlines the role of lifestyle and prevention strategies for GC, in order to reduce the patients’ risk factors, implement the surveillance of precancerous conditions and, therefore, improve the diagnosis of early lesions. Furthermore, we summarize the available treatments for early gastric cancer.

21 November 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
MRMatteo Rottoli
Matteo Rottoli
AGAlice Gori
Alice Gori
GPGianluca Pellino
Gianluca Pellino
MFMaria Elena Flacco
Maria Elena Flacco
CMCecilia Martellucci
Cecilia Martellucci
VCValerio Celentano
Valerio Celentano
Importance: Delays in screening programs and the reluctance of patients to seek medical attention because of the outbreak of SARS-CoV-2 could be associated with the risk of more advanced colorectal cancers at diagnosis.Objective: To evaluate whether the SARS-CoV-2 pandemic was associated with more advanced oncologic stage and change in clinical presentation for patients with colorectal cancer.Design, Setting, and Participants: This retrospective, multicenter cohort study included all 17 938 adult patients who underwent surgery for colorectal cancer from March 1, 2020, to December 31, 2021 (pandemic period), and from January 1, 2018, to February 29, 2020 (prepandemic period), in 81 participating centers in Italy, including tertiary centers and community hospitals. Follow-up was 30 days from surgery.Exposures: Any type of surgical procedure for colorectal cancer, including explorative surgery, palliative procedures, and atypical or segmental resections.Main Outcomes and Measures: The primary outcome was advanced stage of colorectal cancer at diagnosis. Secondary outcomes were distant metastasis, T4 stage, aggressive biology (defined as cancer with at least 1 of the following characteristics: signet ring cells, mucinous tumor, budding, lymphovascular invasion, perineural invasion, and lymphangitis), stenotic lesion, emergency surgery, and palliative surgery. The independent association between the pandemic period and the outcomes was assessed using multivariate random-effects logistic regression, with hospital as the cluster variable.Results: A total of 17 938 patients (10 007 men [55.8%]; mean [SD] age, 70.6 [12.2] years) underwent surgery for colorectal cancer: 7796 (43.5%) during the pandemic period and 10 142 (56.5%) during the prepandemic period. Logistic regression indicated that the pandemic period was significantly associated with an increased rate of advanced-stage colorectal cancer (odds ratio [OR], 1.07; 95% CI, 1.01-1.13; P = .03), aggressive biology (OR, 1.32; 95% CI, 1.15-1.53; P < .001), and stenotic lesions (OR, 1.15; 95% CI, 1.01-1.31; P = .03).Conclusions and Relevance: This cohort study suggests a significant association between the SARS-CoV-2 pandemic and the risk of a more advanced oncologic stage at diagnosis among patients undergoing surgery for colorectal cancer and might indicate a potential reduction of survival for these patients.

1 September 2020 in European Urology
Verified
Journal Article
Closed access
ALAlessandro Larcher
Alessandro Larcher
GFGiuseppe Fallara
Giuseppe Fallara
GRGiuseppe Rosiello
Giuseppe Rosiello
CRChiara Re
Chiara Re
GBGianfranco Baiamonte
Gianfranco Baiamonte
UCUmberto Capitanio
Umberto Capitanio

28 May 2021 in BJU International
Verified
Journal Article
Open access
PDF file
JNJoana B. Neves
Joana B. Neves
RVRebecca Varley
Rebecca Varley
Stefano AgnesiStefano Agnesi
Stefano Agnesi
JWJohn Withington
John Withington
FRFilipe Brogueira Rodrigues
Filipe Brogueira Rodrigues
MTMaxine G. B. Tran
Maxine G. B. Tran
Objectives: To study the natural history of renal oncocytomas and address indications for intervention by determining how growth is associated with renal function over time, the reasons for surgery and ablation, and disease‐specific survival. Patients and Methods: The study was conducted in a retrospective cohort of consecutive patients with renal oncocytoma on active surveillance reviewed at the Specialist Centre for Kidney Cancer at the Royal Free London NHS Foundation Trust (2012 to 2019). Comparison between groups was performed using Mann–Whitney U ‐tests and chi‐squared tests. A mixed‐effects model with a random intercept for patient was used to study the longitudinal association between tumour size and estimated glomerular filtration rate (eGFR). Results: Longitudinal data from 98 patients with 101 lesions were analysed. Most patients were men (68.3%) and the median (interquartile range [IQR]) age was 69 (13) years. The median (IQR) follow‐up was 29 (26) months. Most lesions were small renal masses, and 24% measured over 4 cm. Over half (64.4%) grew at a median (IQR) rate of 2 (4) mm per year. No association was observed between tumour size and eGFR over time ( P = 0.871). Nine lesions (8.9%) were subsequently treated. Two deaths were reported, neither were related to the diagnosis of renal oncocytoma. Conclusion: Natural history data from the largest active surveillance cohort of renal oncocytomas to date show that renal function does not seem to be negatively impacted by growing oncocytomas, and confirms clinical outcomes are excellent after a median follow‐up of over 2 years. Active surveillance should be considered the 'gold standard' management of renal oncocytomas up to 7cm.

2 April 2024 in Updates in Surgery
Verified
Journal Article
Open access
PDF file
Stefano AgnesiStefano Agnesi
Stefano Agnesi
GLGabriele Mauro Di Lucca
Gabriele Mauro Di Lucca
FBFabio Benedetti
Fabio Benedetti
LFLuca Fattori
Luca Fattori
LDLuca Degrate
Luca Degrate
MCMarco Ceresoli
Marco Ceresoli
Appendicitis is one of the most common abdominal emergencies. Evidence is controversial in determining if the in-hospital time delay to surgery can worsen the clinical presentation of appendicitis. This study aimed to clarify if in-hospital surgical delay significantly affected the proportion of complicated appendicitis in a large prospective cohort of patients treated with appendectomy for acute appendicitis. Patients were grouped into low, medium, and high preoperative risk for acute appendicitis based on the Alvarado scoring system. Appendicitis was defined as complicated in cases of perforation, abscess, or diffuse peritonitis. The primary outcome was correlation of in-hospital delay with the proportion of complicated appendicitis. The study includes 804 patients: 278 (30.4%) had complicated appendicitis and median time delay to surgery in low-, medium-, and high-risk group was 23.15 h (13.51–31.48), 18.47 h (10.44–29.42), and 13.04 (8.13–24.10) h, respectively. In-hospital delay was not associated with the severity of appendicitis or with the presence of postoperative complications. It appears reasonably safe to delay appendicectomy for acute appendicitis up to 24 h from hospital admission. Duration of symptoms was a predictor of complicated appendicitis and morbidity. Timing for appendicectomy in acute appendicitis should be calculated from symptoms onset rather than hospital presentation.

1 April 2023 in Minerva Surgery
Verified
Journal Article
Closed access
FCFederico Cozzani
Federico Cozzani
Stefano AgnesiStefano Agnesi
Stefano Agnesi
PDPaolo Dell’aBate
Paolo Dell’aBate
MRMatteo Rossini
Matteo Rossini
LVLorenzo Viani
Lorenzo Viani
PRPaolo DEL Rio
Paolo DEL Rio
Article: The prognostic role of metastatic lymph node ratio in colon cancer: a retrospective cohort study on 241 patients in a single center - Minerva Surgery 2022 Oct 04 - Minerva Medica - Journals